County of Kent, United Kingdom

Michael George Dodd

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Pfizer Corporation. Active years: 2005.



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael George Dodd: Innovator in Therapeutic Compositions

Introduction

Michael George Dodd is a notable inventor based in the County of Kent, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compositions. His work focuses on enhancing cardiovascular health through innovative drug formulations.

Latest Patents

Michael George Dodd holds 1 patent for his invention titled "Therapeutic compositions comprising excess enantiomer." This patent addresses pharmaceutical compositions that include a mixture of amlodipine enantiomers. These compositions are designed to provide both anti-hypertensive effects and additional cardiovascular benefits. The unique properties of these compositions stem from their calcium channel-blocking activity and their ability to release vascular nitric oxide (NO).

Career Highlights

Throughout his career, Michael has been associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative therapeutic solutions that address critical health issues.

Collaborations

Michael has collaborated with esteemed colleagues, including Michael John Humphrey and Suresh Babubhai Chahwala. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compositions.

Conclusion

Michael George Dodd's contributions to the field of therapeutic compositions exemplify the impact of innovation in pharmaceuticals. His work continues to influence the development of effective treatments for cardiovascular health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…